SMHGF (SMHGF PINK) stock market data APIs
$0.6907
0(0%)
as of September 15, 2025
Try our APIs with
free plan!
SMHGF Financial Data Overview
Price chart is built with
Anychart
Simcere Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. The company focuses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN simnotrelvir tablets and ritonavir tablets. The company also offers promotional services for pharmaceutical products. In addition, it engages in the manufacture of pharmaceutical ingredients and its property management business. The company was founded in 1995 and is headquartered in Nanjing, China.
Prev. Close
0.6907
Open
0.6907
High
0.6907
Low
0.6907
52 wk Range
0.6699-0.7585
Market Cap
1 797 M
P/E Ratio
17.305
Shares Outstanding
2 596 M
Revenue
7 107 M
Dividends (Yield)
0.2311
Beta
0.525
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SMHGF data using free add-ons & libraries
Get SMHGF Fundamental Data
SMHGF Fundamental data includes:
- Net Revenue: 7 107 M
- EBITDA: 1 491 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-21
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SMHGF News
New
Simcere Pharmaceutical Group (SEHK:2096) Completes HK$2 Billion Follow-On Equity Offering
Simcere Pharmaceutical Group recently completed a follow-on equity offering, raising HKD 1.57 billion, which coincided with a 10.69% increase in the company's share price over the past month. The acce...
Asian Market's Estimated Value Stocks For August 2025
As the Asian markets navigate a landscape influenced by global economic shifts, including potential rate cuts and evolving trade dynamics, investors are keenly observing opportunities for value invest...
Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
Pyxis Oncology – Phase 1 monotherapy expansion study of micvotabart pelidotin (MICVO) for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients progressing well with...
3 Asian Stocks Estimated To Be Up To 48.5% Below Intrinsic Value
Amid the backdrop of significant trade developments and economic shifts, Asian markets have shown resilience with notable gains in key indices. As global investors navigate these evolving conditions, ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
